Magnus Medical Launches with Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Desig

Related Keywords

United States ,Americans ,American ,Brett Wingeier ,Romain Moreau Gobard ,Heath Lukatch ,Andrew Firlik ,Scott Ashworth ,Brandon Bentzley ,Us Food Drug Administration ,Magnus Medical Inc ,Stanford University ,Magnus Medical ,Drug Administration ,Breakthrough Device Designation ,Red Tree Venture ,Red Tree Venture Capital ,Magnus System ,American Journal ,Depression Rating Scale ,Breakthrough Device ,Tree Venture Capital ,San Francisco Bay Area ,Newswise ,Ajor Depressive Disorder Mdd Mental Health Neurostimulation Randomized Controlled Trial ,All Journal News ,Mental Health ,Euro ,Sychology And Psychiatry ,Grant Funded News ,